Schedule 13G ownership disclosure
Emmaus Life Sciences, Inc.
COMMON STOCK, PAR VALUE $0.001 PER SHARE · CUSIP: 29137T101
Event date: 2024-12-31
- Filing-level shares
- 4,147,426.00
- Percent of class
- 6.5%
- Seah H. Lim, M.D., Ph.D.
Shares: 4,147,426.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-009790
- Form type
- SCHEDULE 13G/A
- Filer
- Emmaus Life Sciences, Inc.
- CIK
- CIK 822370
- Filed
- Feb 04, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership